Short Interest in Aclarion, Inc. (NASDAQ:ACON) Decreases By 99.8%

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 13,500 shares, a drop of 99.8% from the January 15th total of 7,750,000 shares. Based on an average daily trading volume, of 335,300 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Ascendiant Capital Markets decreased their price target on shares of Aclarion from $502.50 to $435.50 and set a “buy” rating on the stock in a research note on Wednesday, November 27th. Maxim Group reissued a “hold” rating on shares of Aclarion in a report on Friday, December 13th.

Aclarion Stock Performance

Aclarion stock opened at $4.73 on Friday. The stock’s fifty day moving average price is $24.33 and its two-hundred day moving average price is $52.58. Aclarion has a one year low of $3.86 and a one year high of $626.45.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.